HMGB1 and glomerulonephritis: The use of the neutralizing antibody anti-HMGB1 in the treatment of lupus-prone BXSB mice can reduce the concentration of proteinuria, glomerulonephritis, circulating anti-dsDNA, immune complex deposition, and plasma cytokines22.